Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT05478967
Eligibility Criteria:
Inclusion Criteria:
* type 2 diabetes mellitus
* age between 35 and 65
* PDR who underwent primary pars plana vitrectomy for VH.
Exclusion Criteria:
* eyes with retinal tear
* eyes with iris or anterior angle neovascularization
* eyes with intraoperative use of silicone oil
* eyes with choroidal or retinal disease other than PDR or any inflammation condition
* eyes underwent any previous vitrectomy or scleral buckle surgery
* eyes received intraocular TA injection within 90 days before screening
* eyes received intraocular anti VEGF treatment within 60 days before screening or contralateral eyes received intraocular anti VEGF treatment during follow-up
* patients who had taken aspirin orally within 7 days before screening
* patient has coagulation mechanism disorder or other medicine for anticoagulant treatment
* cerebrovascular accident and / or myocardial infarction occurred within 180 days before screening
* patients with uncontrolled blood pressure (sitting position \> 160 / 100 mmHg)
* patients with liver or kidney dysfunction or any severe systemic disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
65 Years
Study:
NCT05478967
Study Brief:
Protocol Section:
NCT05478967